Insider Transactions Reported by 12 Insiders of Lexaria Bioscience Corp.

Symbol
LEXX, LEXXW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Kelowna, British Columbia, Canada

Insiders trading volume in the past year

Lexaria Bioscience Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Christopher Bunka Director $743K +$25.2K +3.52% Jul 29, 2025
Richard Christopher Chief Executive Officer, Director $364K +$13.6K +3.9% Jul 29, 2025
John Docherty President & CSO, Director $322K +$4.99K +1.57% Jul 29, 2025
Michael Shankman Chief Financial Officer $122K May 15, 2025
Nicholas Baxter Director $90.3K May 15, 2025
William McKechnie Director $71.3K +$4.53K +6.79% Jul 29, 2025
Vanessa Carle Secretary $65.9K +$683 +1.05% Jul 29, 2025
Albert Reese Director $65.8K May 15, 2025
Baljinder Bhullar Director $15.9K May 15, 2025
Catherine C. Turkel Director $9.7K Aug 12, 2024
Gregory Downey Chief Financial Officer $4.08K Oct 14, 2022
Nelson Cabatuan Chief Financial Officer Mar 14, 2024

Recent Insider Transactions by Companies or Individuals for Lexaria Bioscience Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.